advertisement

WGA Rescources

Huang C 25

Showing records 1 to 25 | Display all abstracts from Huang C

121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Wu SN
Therapeutic advances in drug safety 2024; 15: 20420986241285929
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Liu L
Photodiagnosis and photodynamic therapy 2024; 49: 104271
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Wu SN; Chen XD
Clinical and Experimental Ophthalmology 2024; 0:
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Huang C
Therapeutic advances in drug safety 2024; 15: 20420986241285929
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Chen XD
Clinical and Experimental Ophthalmology 2024; 0:
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Lin Y
Photodiagnosis and photodynamic therapy 2024; 49: 104271
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Yan D
Clinical and Experimental Ophthalmology 2024; 0:
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Xie X
Photodiagnosis and photodynamic therapy 2024; 49: 104271
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Wang YQ
Therapeutic advances in drug safety 2024; 15: 20420986241285929
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Wang YQ
Clinical and Experimental Ophthalmology 2024; 0:
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Peng J
Photodiagnosis and photodynamic therapy 2024; 49: 104271
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Li X
Therapeutic advances in drug safety 2024; 15: 20420986241285929
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Huang C
Photodiagnosis and photodynamic therapy 2024; 49: 104271
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Wang SP
Clinical and Experimental Ophthalmology 2024; 0:
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Zhang SQ
Therapeutic advances in drug safety 2024; 15: 20420986241285929
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Ma D
Photodiagnosis and photodynamic therapy 2024; 49: 104271
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Chen XD
Therapeutic advances in drug safety 2024; 15: 20420986241285929
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Guan WY
Clinical and Experimental Ophthalmology 2024; 0:
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Chen XD; Qin DY
Therapeutic advances in drug safety 2024; 15: 20420986241285929
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Huang C
Clinical and Experimental Ophthalmology 2024; 0:
122735 The diagnostic ability of peripapillary vessel density in primary open-angle glaucoma suspects
Zhang M
Photodiagnosis and photodynamic therapy 2024; 49: 104271
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Hu J
Clinical and Experimental Ophthalmology 2024; 0:
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Zhu L; Wen JY
Therapeutic advances in drug safety 2024; 15: 20420986241285929
120254 Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database
Liu Z
Clinical and Experimental Ophthalmology 2024; 0:
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Luo NC; Hu J; Liu Z
Therapeutic advances in drug safety 2024; 15: 20420986241285929

Issue 25-1

Change Issue


advertisement

Nidek